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Abstract
Background: The sequencing of genomes of the Plasmodium species causing malaria, offers
immense opportunities to aid in the development of new therapeutics and vaccine candidates
through Bioinformatics tools and resources.
Methods: The starting point of MalVac database is the collection of known vaccine candidates and
a set of predicted vaccine candidates identified from the whole proteome sequences of Plasmodium
species provided by PlasmoDb 5.4 release (31st October 2007). These predicted vaccine
candidates are the adhesins and adhesin-like proteins from Plasmodium species, Plasmodium
falciparum, Plasmodium vivax and Plasmodium yoelii. Subsequently, these protein sequences were
analysed through 20 publicly available algorithms to obtain Orthologs, Paralogs, BetaWraps,
TargetP, TMHMM, SignalP, CDDSearch, BLAST with Human Ref. Proteins, T-cell epitopes, B-cell
epitopes, Discotopes, and allergen predictions. All of this information was collected and organized
with the ORFids of the protein sequences as primary keys. This information is relevant from the
view point of Reverse Vaccinology in facilitating decision making on the most probable choice for
vaccine strategy.
Results: Detailed information on the patterning of the epitopes and other motifs of importance
from the viewpoint of reverse vaccinology has been obtained on the most probable protein
candidates for vaccine investigation from three major malarial species. Analysis data are available
on 161 adhesin proteins from P. falciparum, 137 adhesin proteins from P. vivax and 34 adhesin
proteins from P. yoelii. The results are displayed in convenient tabular format and a facility to export
the entire data has been provided. The MalVac database is a "community resource". Users are
encouraged to export data and further contribute by value addition. Value added data may be sent
back to the community either through MalVac or PlasmoDB.
Conclusion:  A web server MalVac for facilitation of the identification of probable vaccine
candidates has been developed and can be freely accessed.
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Background
Malaria is a major killer disease. Annually, about 500 mil-
lion people get infected and an estimated 1 million deaths
occur. Despite numerous efforts we still do not have effec-
tive vaccines [1]. Among the parasites that cause malaria,
the most common and widely distributed is Plasmodium
vivax [2]. But the most fatal form of malaria is caused by
Plasmodium falciparum [3].  Plasmodium yoelii is a com-
monly used rodent malaria parasite as a model to study
malaria infection. Malaria caused by P. yoelii has similari-
ties to that caused by P. falciparum and P. vivax [4].
Currently, several vaccines against multiple stages are in
clinical development, including pre-erythrocytic, blood
stage and others [3]. Although these advancements raise
the hopes of the availability of an effective vaccine, it is
noted that our limited knowledge on the details of the
immune responses is becoming a major handicap [1]. The
availability of complete genome sequences of Plasmodium
falciparum [5], P. yoelii [4] and P. vivax has provided new
opportunity for applying the principles of Reverse Vacci-
nology. Reverse vaccinology uses bioinformatics in the
initial steps to identify potential antigens, which are sub-
sequently examined for their efficacy and toxicity. In its
maiden application, use of algorithm for prediction of
sub-cellular location boosted the power of identifying
potential vaccine candidates [6]. Subsequently, enhance-
ments have been proposed to reverse vaccinology by sug-
gesting the use of additional algorithms to find
probability of being an adhesin, of topology (transmem-
brane regions) and to find similarity with host protein [7].
Recently, integrative approaches are proposed for Reverse
Vaccinology by including prediction of multiple features
of proteins [8]. Adopting this strategy, the following pre-
dictions were incorporated: of adhesins [9] and their
orthologs [10], paralogs [11], transmembrane topologies
[12], beta helix supersecondary structural motifs [13],
subcellular localization [14,15], similarity against Human
proteins [16], antigenic regions [17], conserved
domains[18], epitopes [19-26] and allergens [27-29]. The
work flow started with adhesin prediction algorithm,
which holds an important position in vaccine develop-
ment process. The adhesin proteins mediate the adher-
ence of malaria parasites to the host cells and facilitate
invasion. Targeting these adhesins to abrogate the coloni-
zation process can prevent malaria infection [9,30].
The multiple features of potential vaccine candidates cou-
pled with information on the current candidates being
pursued can be queried through a user friendly interface.
These data are housed in MalVac database, which can aid
in the discovery of adhesin based vaccines.
Methods
Database architecture
The ORF identification tags (ORF ID) assigned to proteins
of malaria parasites as given in PlasmoDB 5.4 release of
31st October 2007 [31] were used as primary keys. The
database was developed using MySQL version 4.1.20 at
back end and operated in Red Hat Enterprise Linux ES
release 4. The web interfaces have been developed in
HTML and PHP 5.1.4, which dynamically execute the
MySQL queries to fetch the stored data and is run through
Apache2 server. The overall layout of MalVac is provided
in Figure 1.
The first step towards MalVac database creation is the col-
lection of known vaccine candidates and a set of predicted
vaccine candidates identified from the whole proteome
sequences of Plasmodium species provided by PlasmoDB
5.4 release(31st October 2007). These predicted vaccine
candidates are the adhesins and adhesin-like proteins
from Plasmodium species, P. falciparum, P. vivax and P.
yoelii using MAAP server [9]. Subsequently these protein
sequences were analysed with 20 algorithms important
from the view of reverse vaccinology (Table 1).
Database access and interface
MalVac Database is freely available [32]. A user friendly
web-based interface allows users to explore the site and
fetch the data corresponding to their queries. For example,
if the user needs to search database for data on a set of pro-
teins given by their ORF identification tags one starts with
clicking the "Database Search" button (Figure 2). This
would take the user to the "MalVac Query Page". Here the
user can search the database for adhesin proteins and their
attributes corresponding to one or more ORF identifica-
tion tags of a species or against a specific Keyword. To
fetch the required data the corresponding checkboxes
need to be toggled 'on' followed by clicking the submit
button (Figure 3). The results are displayed in convenient
tabular format and a facility to export the entire data has
been provided. To get the Epitope and Allergen data the
user must provide a specific ORF ID along with the species
selected.
Advanced search facility of predicted malarial adhesins is
also provided where the results can be filtered on the basis
of Protein length, number of transmembrane spanning
regions, localization and reliability class, presence or
absence of betawraps, paralogs, orthologs, hits to Con-
served Domain Database and Human Reference proteins
(retrieved from NCBI through ftp on April 22, 2008). The
results obtained can be exported by the user. The known
vaccines link takes user to the page containing the list of
known vaccine candidates provided in tabular form. This
data can again be exported by the user. Facility to post
comments by the user has been provided in MalVac webMalaria Journal 2008, 7:184 http://www.malariajournal.com/content/7/1/184
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interface. Users can post their value added comments and
suggestions on specific genes based on their own experi-
ence through the comment posting page of MalVac.
Results and Discussion
MalVac Database contains analysis data on 332 potential
vaccine candidates on three most important Plasmodium
species. Of these, 161 are from P. falciparum, 137 are from
P. vivax and 34 are from P. yoelii. First level of searching
and retrieval of data is possible either through ORF ID or
keywords. Multiple ORF IDs can be submitted using
comma separation. Keywords can be used singly. If multi-
ple keywords are used then the search is implemented
using the AND Boolean. In the case of searching for
epitope data, due to their huge size, data are conveniently
retrieved in a singular mode for each ORF ID specifically.
All data can be exported conveniently as a text file.
The database houses detailed information on these vac-
cine candidates analysed through 20 algorithms impor-
tant from the view of reverse vaccinology. The analysis
through these algorithms provide a broad range of infor-
mation regarding Orthologs, Paralogs, BetaWraps, Locali-
zation, Transmembrane spanning regions, Signal
Peptides, Conserved domains, similarity to Human Refer-
ence Proteins, T-cell epitopes, B-cell epitopes, Discotopes,
and Allergen predictions.
Advanced level searches are also provided. In this facility
users can search using combined feature selection. The
most immediate application of such a scheme is in filter-
ing for candidate proteins meeting a certain set of specifi-
cations. For example users formulate their queries by
selecting for proteins that have less (or greater) than a
specified number of transmembrane domains and less (or
greater) than a specified length of protein. The features on
which users can formulate their search could be based on
Protein length, number of transmembrane spanning
regions, localization-reliability class, presence or absence
of betawraps, paralogs, orthologs, hits to CDD and
The MalVac layout Figure 1
The MalVac layout. All data are organized in relation to the primary key ORF ID.Malaria Journal 2008, 7:184 http://www.malariajournal.com/content/7/1/184
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Table 1: Algorithms used to predict molecular features of potential malarial vaccine candidates and housed in MalVac.
Algorithm Principle Role in MalVac Reference
1. MAAP Predicts Malarial adhesins and adhesins-like proteins based on 
Support Vector Machines
Adhesin and Adhesin like 
protein prediction.
[9]
2. BLASTCLUST Clusters protein or DNA sequences based on pair wise 
matches found using the BLAST algorithm in case of proteins 
or Mega BLAST algorithm for DNA.
Paralogs finding [11]
3. TMHMM Server v. 2.0 Predicts the transmembrane helices in proteins based on 
Hidden Markov Model.
Transmembrane helices 
prediction
[12]
4. BetaWrap Predicts the right-handed parallel beta-helix supersecondary 
structural motif in primary amino acid sequences by using 
beta-strand interactions learned from non-beta-helix 
structures.
Betawrap finding [13]
5. TargetP1.1 Predicts the subcellular location of eukaryotic proteins based 
on the predicted presence of any of the N-terminal 
presequences: chloroplast transit peptide (cTP), 
mitochondrial targeting peptide (mTP) or secretory pathway 
signal peptide (SP).
Localization Prediction. [14]
6. SignalP 3.0 Predicts the presence and location of signal peptide cleavage 
sites in amino acid sequences from different organisms. The 
method incorporates a prediction of cleavage sites and a signal 
peptide/non-signal peptide prediction based on a combination 
of several artificial neural networks and hidden Markov 
models.
Signal Peptide Prediction. [15]
7. BlastP It uses the BLAST algorithm to compare an amino acid query 
sequence against a protein sequence database.
Prediction of similarity to human 
reference proteins.
[16]
8. Antigenic Predicts potentially antigenic regions of a protein sequence, 
based on occurrence frequencies of amino acid residue types 
in known epitopes.
Antigenic region prediction. [17]
9. Conserved Domain Database 
and Search Service, v2.13
The Database is a collection of multiple sequence alignments 
for ancient domains and full-length proteins. It is used to 
identify the conserved domains present in a protein query 
sequence.
Conserved Domain Finding [18]
10. ABCPred Predict B cell epitope(s) in an antigen sequence, using artificial 
neural network.
Linear B Cell Epitope Prediction. [19]
11. BcePred Predicts linear B-cell epitopes, using physico-chemical 
properties.
Linear B Cell Epitope Prediction. [20]
12. Discotope 1.1 Predicts discontinuous B cell epitopes from protein three 
dimensional structures utilizing calculation of surface 
accessibility (estimated in terms of contact numbers) and a 
novel epitope propensity amino acid score.
Conformational B Cell Epitope 
Prediction.
[21]
13. CEP The algorithm predicts epitopes of protein antigens with 
known structures. It uses accessibility of residues and spatial 
distance cut-off to predict antigenic determinants (ADs), 
conformational epitopes (CEs) and sequential epitopes (SEs).
Conformational B Cell Epitope 
Prediction
[22]
14. NetMHC 2.2 Predicts binding of peptides to a number of different HLA 
alleles using artificial neural networks (ANNs) and weight 
matrices.
HLA Class I Epitope prediction. [23]
15. MHCPred 2.0 MHCPred uses the additive method to predict the binding 
affinity of major histocompatibility complex (MHC) class I and 
II molecules and also to the Transporter associated with 
Processing (TAP). Allele specific Quantitative Structure 
Activity Relationship (QSAR) models were generated using 
partial least squares (PLS).
MHC Class I and II epitope 
prediction.
[24]
16. Bimas Ranks potential 8-mer, 9-mer, or 10-mer peptides based on a 
predicted half-time of dissociation to HLA class I molecules. 
The analysis is based on coefficient tables deduced from the 
published literature by Dr. Kenneth Parker, Children's 
Hospital Boston.
HLA Class I Epitope prediction. [25]
17. Propred Predicts MHC Class-II binding regions in an antigen sequence, 
using quantitative matrices derived from published literature. 
It assists in locating promiscous binding regions that are useful 
in selecting vaccine candidates.
Promiscous MHC Class II 
epitope prediction.
[26]Malaria Journal 2008, 7:184 http://www.malariajournal.com/content/7/1/184
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human reference proteins in the advanced search page.
The results obtained can be exported by the user.
Conclusion
MalVac database was built as a community resource to aid
malaria vaccinologists. MalVac is freely available with
facility to export data and use for user's convenience [32].
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18. AlgPred Predicts allergens in query protein based on similarity to 
known epitopes, searching MEME/MAST allergen motifs using 
MAST and assign a protein allergen if it have any motif, search 
based on SVM modules and search with BLAST search against 
2890 allergen-representative peptides obtained from 
Bjorklund et al 2005 and assign a protein allergen if it has a 
BLAST hit.
Allergen Prediction [27]
19. Allermatch Predicts the potential allergenicity of proteins by 
bioinformatics approaches as recommended by the Codex 
alimentarius and FAO/WHO Expert consultation on 
allergenicity of foods derived through modern biotechnology.
Allergen Prediction [28]
20. WebAllergen Predicts the potential allergenicity of proteins. The query 
protein is compared against a set of pre-built allergenic motifs 
that have been obtained from 664 known allergen proteins.
Allergen Prediction [29]
Table 1: Algorithms used to predict molecular features of potential malarial vaccine candidates and housed in MalVac. (Continued)
The Home page of MalVac Figure 2
The Home page of MalVac. The "Database Search" facility can be used for first level search. Advanced search is provided in 
the "Search Tools" facility. "Other links" would take users to other websites of malaria for obtaining additional details and the 
"Known Vaccines" tab describes the details of the currently known vaccine candidates.Malaria Journal 2008, 7:184 http://www.malariajournal.com/content/7/1/184
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